Conference item icon

Conference item

Predicting post one-year durability of glucose-lowering monotherapies in patients with new-onset type 2 diabetes

Subtitle:
Conference abstract
Abstract:
Current NICE guidelines for type 2 diabetes (T2D) recommend identifying the most appropriate glucose-lowering therapy for a given individual. This decision depends not only on the initial glycaemic response, but also the durability of its glucose lowering effect over time. We investigated the latter by examining possible predictors of post one-year durability for glucose-lowering monotherapies in people with new-onset T2D.
Publication status:
Published
Peer review status:
Reviewed (other)
Version:
Accepted manuscript

Actions


Access Document


Files:
Publisher copy:
10.1007/s00125-017-4350-z

Authors


More by this author
Institution:
University of Oxford
Division:
Medical Sciences Division
Department:
RDM; OCDEM
More by this author
Institution:
University of Oxford
Division:
Medical Sciences Division
Department:
RDM; OCDEM
Hattersley, AT More by this author
Pearson, EZ More by this author
More by this author
Institution:
University of Oxford
Division:
Medical Sciences Division
Department:
RDM; OCDEM
Expand authors...
Publisher:
Springer Publisher's website
Volume:
60
Issue:
S1
Pages:
300
Publication date:
2017-08-09
Acceptance date:
2017-04-01
DOI:
EISSN:
1432-0428
ISSN:
0012-186X
Pubs id:
pubs:738259
URN:
uri:2c56020d-f1d6-4a77-b3bb-e4bc18386d97
UUID:
uuid:2c56020d-f1d6-4a77-b3bb-e4bc18386d97
Local pid:
pubs:738259

Terms of use


Metrics



If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP